Literature DB >> 20299456

Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor.

Hamiyet Unal1, Rajaganapathi Jagannathan, Manjunatha B Bhat, Sadashiva S Karnik.   

Abstract

The orientation of the second extracellular loop (ECL2) is divergent in G-protein coupled receptor (GPCR) structures determined. This discovery provoked the question, is the ECL2 conformation differentially regulated in the GPCRs that respond to diffusible ligands? We have determined the conformation of the ECL2 of the angiotensin II type 1 receptor by reporter-cysteine accessibility mapping in different receptor states (i.e. empty, agonist-bound and antagonist-bound). We introduced cysteines at each position of ECL2 of an N-terminal epitope-tagged receptor surrogate lacking all non-essential cysteines and then measured reaction of these with a cysteine-reactive biotin probe. The ability of biotinylated mutant receptors to react with a steptavidin-HRP-conjugated antibody was used as the basis for examining differences in accessibility. Two segments of ECL2 were accessible in the empty receptor, indicating an open conformation of ECL2. These segments were inaccessible in the ligand-bound states of the receptor. Using the accessibility constraint, we performed molecular dynamics simulation to predict ECL2 conformation in different states of the receptor. Analysis suggested that a lid conformation similar to that of ECL2 in rhodopsin was induced upon binding both agonist and antagonist, but exposing different accessible segments delimited by the highly conserved disulfide bond. Our study reveals the ability of ECL2 to interact with diffusing ligands and to adopt a ligand-specific lid conformation, thus, slowing down dissociation of ligands when bound. Distinct conformations induced by the bound agonist and the antagonist around the conserved disulfide bond suggest an important role for this disulfide bond in producing different functional states of the receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299456      PMCID: PMC2871501          DOI: 10.1074/jbc.M109.094870

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain.

Authors:  L Duprez; J Parma; S Costagliola; J Hermans; J Van Sande; J E Dumont; G Vassart
Journal:  FEBS Lett       Date:  1997-06-16       Impact factor: 4.124

Review 2.  G protein-coupled receptors. I. Diversity of receptor-ligand interactions.

Authors:  T H Ji; M Grossmann; I Ji
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

3.  Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.

Authors:  M M Zhao; J Hwa; D M Perez
Journal:  Mol Pharmacol       Date:  1996-11       Impact factor: 4.436

4.  Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor.

Authors:  M Ojima; Y Inada; Y Shibouta; T Wada; T Sanada; K Kubo; K Nishikawa
Journal:  Eur J Pharmacol       Date:  1997-01-14       Impact factor: 4.432

5.  Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor.

Authors:  S Miura; Y H Feng; A Husain; S S Karnik
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

6.  Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111).

Authors:  Y H Feng; S Miura; A Husain; S S Karnik
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

Review 7.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

8.  An agonist-like monoclonal antibody against the human beta2-adrenoceptor.

Authors:  D Lebesgue; G Wallukat; A Mijares; C Granier; J Argibay; J Hoebeke
Journal:  Eur J Pharmacol       Date:  1998-05-01       Impact factor: 4.432

9.  Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation.

Authors:  K Noda; Y Saad; S S Karnik
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

10.  Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation.

Authors:  Shivani Ahuja; Viktor Hornak; Elsa C Y Yan; Natalie Syrett; Joseph A Goncalves; Amiram Hirshfeld; Martine Ziliox; Thomas P Sakmar; Mordechai Sheves; Philip J Reeves; Steven O Smith; Markus Eilers
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

View more
  36 in total

1.  Structural insights into human GPCR protein OA1: a computational perspective.

Authors:  Anirban Ghosh; Uddhavesh Sonavane; Sai Krishna Andhirka; Gopala Krishna Aradhyam; Rajendra Joshi
Journal:  J Mol Model       Date:  2011-09-22       Impact factor: 1.810

2.  Ligand Binding Sensitivity of the Extracellular Loop Two of the Cannabinoid Receptor 1.

Authors:  Alexander C Bertalovitz; Kwang H Ahn; Debra A Kendall
Journal:  Drug Dev Res       Date:  2010-11-01       Impact factor: 4.360

3.  Inactive conformation enhances binding function in physiological conditions.

Authors:  Olga Yakovenko; Veronika Tchesnokova; Evgeni V Sokurenko; Wendy E Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.

Authors:  Nicola J Smith; Richard J Ward; Leigh A Stoddart; Brian D Hudson; Evi Kostenis; Trond Ulven; Joanne C Morris; Christian Tränkle; Irina G Tikhonova; David R Adams; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2011-04-15       Impact factor: 4.436

6.  Identification of avian vasotocin receptor subtype-specific antagonists involved in the stress response of the chicken, Gallus gallus.

Authors:  Seong W Kang; Srinivas Jayanthi; Gurueswar Nagarajan; Thallapuranam Krishnaswamy Suresh Kumar; Wayne J Kuenzel
Journal:  J Biomol Struct Dyn       Date:  2018-05-17

7.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

8.  Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.

Authors:  Dany Fillion; Jérôme Cabana; Gaétan Guillemette; Richard Leduc; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

Review 9.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

10.  Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.

Authors:  Haitao Zhang; Hamiyet Unal; Cornelius Gati; Gye Won Han; Wei Liu; Nadia A Zatsepin; Daniel James; Dingjie Wang; Garrett Nelson; Uwe Weierstall; Michael R Sawaya; Qingping Xu; Marc Messerschmidt; Garth J Williams; Sébastien Boutet; Oleksandr M Yefanov; Thomas A White; Chong Wang; Andrii Ishchenko; Kalyan C Tirupula; Russell Desnoyer; Jesse Coe; Chelsie E Conrad; Petra Fromme; Raymond C Stevens; Vsevolod Katritch; Sadashiva S Karnik; Vadim Cherezov
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.